Munaf H. Zalzala

Baghdad, BG 10047, Iraq

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Mechanistic insights into nicardipine's anti-colitic action: inhibition of pro-inflammatory cytokines, attenuation of oxidative stress, and protection of the mucosal barrier.

Mechanistic insights into nicardipine's anti-colitic action: inhibition of pro-inflammatory cytokines, attenuation of oxidative stress, and protection of the mucosal barrier.

Journal: Molecular biology reports

Published: November 12, 2025

The protective role of nicardipine in dextran sulfate sodium-induced colitis in mice: Modulating inflammation and apoptosis.

The protective role of nicardipine in dextran sulfate sodium-induced colitis in mice: Modulating inflammation and apoptosis.

Journal: Toxicology reports

Published: July 13, 2025

FXR crosstalk with other nuclear receptors.

FXR crosstalk with other nuclear receptors.

Journal: Journal of physiology and biochemistry

Published: April 12, 2025

Synergistic action of cilnidipine and bexarotene in mitigating cholestatic liver damage: role of FXR signaling cascade.

Synergistic action of cilnidipine and bexarotene in mitigating cholestatic liver damage: role of FXR signaling cascade.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: December 28, 2024

Novel insights into bexarotene's role in preventing cholestasis: mechanisms and implications.

Novel insights into bexarotene's role in preventing cholestasis: mechanisms and implications.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: December 08, 2024

Ellagic acid mitigates alpha-naphthyl isothiocyanate-induced cholestasis in rats via FXR activation and inflammatory pathway modulation.

Ellagic acid mitigates alpha-naphthyl isothiocyanate-induced cholestasis in rats via FXR activation and inflammatory pathway modulation.

Journal: Journal of complementary & integrative medicine

Published: November 25, 2024

Hepatoprotective Effects of Cilnidipine in Cholestatic Liver Disease: Role of FXR and NRF2 Signalling.

Hepatoprotective Effects of Cilnidipine in Cholestatic Liver Disease: Role of FXR and NRF2 Signalling.

Journal: Journal of experimental pharmacology

Published: November 04, 2024

Farnesoid X Receptor-Mediated Bile Acids Regulation in Cholestasis.

Farnesoid X Receptor-Mediated Bile Acids Regulation in Cholestasis.

Journal: Indian journal of clinical biochemistry : IJCB

Published: September 21, 2024

Papaverine attenuates the progression of alpha naphthylisothiocyanate induce cholestasis in rats.

Papaverine attenuates the progression of alpha naphthylisothiocyanate induce cholestasis in rats.

Journal: Current research in pharmacology and drug discovery

Published: September 27, 2023

Mucoprotective effect of ellagic acid in 5 fluorouracil-induced intestinal mucositis model.

Mucoprotective effect of ellagic acid in 5 fluorouracil-induced intestinal mucositis model.

Journal: Journal of medicine and life

Published: March 03, 2023

Berbamine and thymoquinone exert protective effects against immune-mediated liver injury via NF-κB dependent pathway.

Berbamine and thymoquinone exert protective effects against immune-mediated liver injury via NF-κB dependent pathway.

Journal: Frontiers in veterinary science

Published: June 03, 2022

Association of tumor necrosis factor-alpha promoter region gene polymorphism at positions -308G/A, -857C/T, and -863C/A with etanercept response in Iraqi rheumatoid arthritis patients.

Association of tumor necrosis factor-alpha promoter region gene polymorphism at positions -308G/A, -857C/T, and -863C/A with etanercept response in Iraqi rheumatoid arthritis patients.

Journal: Archives of rheumatology

Published: October 18, 2021

Showing 1-12 of 18

Last Updated: 09/26/2026